chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On March 21, 2021 at around 5:30 I had fever, headache, nausea, fatigue, dizziness. The next day, March 22, I had heart palpitations, dizziness and still fever.  On March 24, 2021 at approximately 8:00 pm, my right leg became heavy and felt numb. On March 25 I woke up to my mouth locked with Bell's Palsy like drooping on the right side of my face.  My mouth remained unable to open fully for the next day and the numbness and pain in my leg increased.  On March 26 I went to the ER because I was afraid I was having a stroke. They gave me tests and said I did not have a stroke. They gave me steroids and they helped with my jaw but the pain in my leg increased. The pain in leg continued with more pain in my knee. I followed up with my family doctor and they sent me to have an ultrasound of my leg to check for a blood clot on April 9th No blood clot was found. Pain continued and increased so the doctor sent me for an MRI on April 14. MRI showed moderate effusions to the knee joint and I have an appointment with a orthopedic doctor on Tuesday April 20th. I continue to have stabbing pain in my knee and swelling and discomfort.
This spontaneous report was received from a medical assistant concerning an unspecified number of patients of unknown age and gender. On unknown dates, unspecified number of patients were vaccinated with doses of GARDASIL (lot number, expiry date, dose and route unspecified) that was exposed to 49 degrees Fahrenheit (F) for 31 days, which was an unsupported excursion based on in-house stability data. No concomitant therapy was reported. No adverse symptoms were reported. This is one of the two reports from the same source. Additional information has been requested.
Strong impact on either severity of ADHD or effectiveness of medication used for treatment. Symptoms include inability to focus, hyperactivity, and severe time blindness.
The patient presents with back pain and lumbar pain.  The onset was 3.5  weeks ago.  The course/duration of symptoms is Coming and going.  Type of injury: none.  Location: lumbar. Radiating pain: none. The character of symptoms is stabbing.  The degree at onset was minimal.  The degree at present is moderate.  The exacerbating factor is none.  The relieving factor is none.  Risk factors consist of coronary artery disease and hypertension.  Prior episodes: occasional.  Therapy today: prescription medications including Augmentin.  The patient presents to the emergency department with a 3-4 week history of low back pain.  He reports the pain is been coming and going.  He reports that makes  Tested positive on 9/6/2021  The degree at present is moderate.  The exacerbating factor is none.  The relieving factor is none.  Risk factors consist of coronary artery disease and hypertension.  Prior episodes: occasional.  Therapy today: prescription medications including Augmentin.  The patient presents to the emergency department with a 3-4 week history of low back pain.  He reports the pain is been coming and going.  He reports that makes it difficult to sleep at night.  He reports that he has had associated problems with urinating.  He reports that when he has the urge to urinate he has had the ability to get to the bathroom quickly and ends up having incontinence.  The patient reports that he has seen his physician regarding this and was given a prescription for Augmentin, however he is unsure exactly why.  He reports that prior to this he was also on another antibiotic.  The patient reports a past medical history of having a bladder cancer with localized chemotherapy to the bladder, and history of kidney cancer with right nephrectomy.  He denies having any associated nausea, vomiting, or diarrhea.  He denies having any chest pain, chest pressure, or shortness of breath.  The patient arrives with a low-grade temp of 100.1°.  He denies any bowel incontinence.  He denies having any numbness or tingling to his extremities, weakness of his extremities, or saddle anesthesia.  He denies any recent trauma or fall.  He reports that years ago he did fall off a roof and broke a bone in his back, however he did not require any surgery..
Previously normal period. First period after vaccine with significantly increased and painful cramping not relieved by otc pain medication. Large clots present. I do not normally have any clots
could not sleep; itching; pain at injection site which went away but came back on Friday night 26Mar2021 and was green in color; Rash around the injection site and it was pink in color; Pain at injection site; Arm swollen; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (could not sleep), PRURITUS (itching), VACCINATION SITE DISCOLOURATION (pain at injection site which went away but came back on Friday night 26Mar2021 and was green in color), VACCINATION SITE SWELLING (Arm swollen) and VACCINATION SITE PAIN (Pain at injection site) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included FENOFIBRATE and FISH OIL for an unknown indication.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced VACCINATION SITE SWELLING (Arm swollen). On 22-Mar-2021, the patient experienced VACCINATION SITE PAIN (Pain at injection site). On 26-Mar-2021, the patient experienced INSOMNIA (could not sleep), PRURITUS (itching), VACCINATION SITE DISCOLOURATION (pain at injection site which went away but came back on Friday night 26Mar2021 and was green in color) and VACCINATION SITE RASH (Rash around the injection site and it was pink in color). At the time of the report, INSOMNIA (could not sleep), PRURITUS (itching), VACCINATION SITE DISCOLOURATION (pain at injection site which went away but came back on Friday night 26Mar2021 and was green in color), VACCINATION SITE SWELLING (Arm swollen), VACCINATION SITE PAIN (Pain at injection site) and VACCINATION SITE RASH (Rash around the injection site and it was pink in color) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   It was reported that the patient also took one a day multivitamin and hand skin and nails gummies as concomitant medications. No treatment medications were reported.
During the first week I experienced prickly heat from the injection site through to the right half of my face. I experience this only the first week and it happened four times with each time the severity getting  more noticeable. During the third week I experience episodes of chest pain or tightness of chest in the center of my chest. This only happened during week three and happened about four times with severity increasing with each episode. I experience shortness of breath the entire three weeks. When I walked up the stairs it was as if I had run up 10 flights of stairs.
Patient had received a SHINGRIX shot on 07/30/2018. Patient had returned to the pharmacy on 08/05/2018 complaining of pain that  began on  07/30/2018 in the evening  after her shot. The pain radiates from the middle of her right back to the front below her breast. She described the pain as being sharp and was temporarily able to relieve the pain with ibuprofen. She did not inform her physician regarding the pain and was advised to call her physician as soon as possible.
Patient claims 1 day after vaccine a sore throat, 2 days after vaccine a full body rash.
Patient passed away in May 2020. Experienced CIDP complications per office note. Daughter expressed that complications began after the patient received the flu shot in October 2019. Requested that report of adverse event was submitted.
Systemic: Allergic: Itch (specify: facial area, extremeties)-Medium, Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Mild, Systemic: Chills-Severe, Systemic: Dizziness / Lightheadness-Medium, Systemic: Flushed / Sweating-Severe, Systemic: Nausea-Severe, Systemic: Shakiness-Mild
Ecchymosis/bruising Swelling and pain in left leg/ankle Cough Malaise Fatigue Chrones flare: GI/Head/Pain Shortness of breath can?t exert self physically  brain fog Headache Disorientation Dizziness/Vertigo brain fog/worsening memory loss of appetite  chills/cold all the time weight loss Kaleidoscope vision Ecchymosis Swollen left leg/ankle Achy/painful joints and muscles Depression/Anxiety Sleep apnea worsening Insomnia loss/change taste smell metallic taste and smell on breath Phantom smells- ammonia, gas, sweet smells Burning/tingling sensations Stronger headaches/migraines Hematuria Chrohns symptom flares Allergy symptoms uncontrolled/increased Upper respiratory infection Memory and cognitive issues Uncontrolled hypertension (with medication) Low and High peeks Neuropathy
3SEP93 mom called MD @ home to notify of golf-ball sized knot on rt leg, pt screaming, not eating well very sensitive to touch of rt leg; MD advised cool compresses to rt leg of 5 minutes;
Information has been received from a 70 year old female nurse practitioner with coeliac disease, latex allergy and allergy to "INASPINE" who on 10-APR-2007 at approximately 14:00 was vaccinated intramuscularly, into the deltoid, with a 0.5 ml second dose of Pneumovax 23 (lot #"0577B").  Concomitant therapy included PAMELOR, ATIVAN and ZANTAC.  On 10-APR-2007 the patient developed fever with a painful, swollen and reddened arm from the injection site at the deltoid, to her neck and down her arm.  She also experienced a painful wrist, elbow and shoulder.  She reported the reaction to her physician by phone.  She underwent electrocardiogram and "routine annual physical labwork" (results not reported).  She treated the swollen arm with elevation and immobility.  At the time of the report, the patient was recovering from painful arm from the injection site at the deltoid, to her neck and down her arm and painful shoulder, wrist and elbow.  She reported that her arm continued to ache although the swelling, fever and redness had resolved.  The nurse practitioner received previous vaccination in approximately 1997 without any reactions.  Additional information has been requested. Additional information is not expected.
Information has been received from a health professional concerning a 77 year old male with no known allergies who on 06-FEB-2007 was vaccinated IM in the right arm with a 1 ml dose of Zostavax (lot # 656412/1476F). The Zostavax was reconstituted with Gardasil (lot # 654741/1208F) and the combined product was administered to the patient. It was reported that the patient was on an unspecified concomitant medication. No symptoms have been reported. Unspecified medical attention was sought. There was no product quality complaint involved. Additional information has been requested.
Tightness in chest; rapid heart rate (90-115bpm); Lightheaded, dizzy; Nasal discharge (runny nose); asthma exacerbation; Generally weak; Right arm was a little red at the injection site; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of CHEST DISCOMFORT (Tightness in chest), HEART RATE INCREASED (rapid heart rate (90-115bpm)), DIZZINESS (Lightheaded, dizzy), RHINORRHOEA (Nasal discharge (runny nose)) and ASTHMA (asthma exacerbation) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K20A and 027A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Pollen allergy, Sulfonamide allergy and Asthma (mild-intermittent and normally only occurs with seasonal allergies, smoke or upper respiratory infections.).   On 08-Jan-2021 at 3:45 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Jan-2021, the patient experienced CHEST DISCOMFORT (Tightness in chest), HEART RATE INCREASED (rapid heart rate (90-115bpm)), DIZZINESS (Lightheaded, dizzy), RHINORRHOEA (Nasal discharge (runny nose)), ASTHMA (asthma exacerbation), ASTHENIA (Generally weak) and VACCINATION SITE ERYTHEMA (Right arm was a little red at the injection site). The patient was treated with PARACETAMOL (TYLENOL) for Vaccination site erythema, at an unspecified dose and frequency and GUAIFENESIN (MUCINEX) for Adverse event, at an unspecified dose and frequency. On 08-Jan-2021, HEART RATE INCREASED (rapid heart rate (90-115bpm)) had resolved. On 21-Feb-2021, CHEST DISCOMFORT (Tightness in chest), RHINORRHOEA (Nasal discharge (runny nose)), ASTHMA (asthma exacerbation) and ASTHENIA (Generally weak) had resolved. At the time of the report, DIZZINESS (Lightheaded, dizzy) and VACCINATION SITE ERYTHEMA (Right arm was a little red at the injection site) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Jan-2021, Heart rate: 100-115 bpm (High) 100-115 bpm.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient visited the physician on 13-Jan-2021 and 02-Feb-2021 as she could not get asthma under control. She started using inhalers as soon as the asthma started and this continued through the end of February. Concomitant medications were not provided.     Most recent FOLLOW-UP information incorporated above includes: On 08-Apr-2021: Contact information, patient demographics,medical history, product and event information updated.
HEADACHE; COLD FLUSH  THROUGH BODY IMMEDIATELY FOLLOWING INJECTION; This spontaneous report received from a patient concerned a 59 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included diabetes - non insulin, and azithromycin allergy, and other pre-existing medical conditions included the patient was not pregnant at the time of reporting. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805029, and batch number: 1805029 expiry: UNKNOWN) .5 ml, administered on 09-MAR-2021 08:30 to Left Arm for prophylactic vaccination. No concomitant medications were reported. On 09-MAR-2021, the subject experienced cold flush through body immediately following injection. On 09-MAR-2021 14:00, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from cold flush through body immediately following injection on 09-MAR-2021, and had not recovered from headache. This report was non-serious.
Arm was really sore the following day, but then got better. About a week later though, the injection site is super red (about 2 inch diameter), it's a little stiff under the skin (like from a spider bite), it's warm to the touch, and it barely and only sometimes itches (more like you brush against it vs consciously needing to scratch at it)
Resident reported weakness, chills, bodyaches, fatigue BP 139/70 Pulse 85 Resp rate 30 Sent to ER for evaluation, admitted to Medical Center
vomited; diarrhea; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A 6 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administration date 23Nov2021 (Batch/Lot number: unknown) at the age of 6 years as dose 1 (tris), single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: VOMITING (non-serious) with onset 25Nov2021 03:30, outcome "recovered" (2021), described as "vomited"; DIARRHOEA (non-serious) with onset 25Nov2021 03:30, outcome "recovered" (2021), described as "diarrhea". Therapeutic measures were not taken as a result of vomiting, diarrhoea.  Additional Information: About 42 hours after her first dose, she woke up in the night and vomited and had diarrhea. The patient didn't had any covid prior vaccination and was not tested post vaccination.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
pt recv vax & exp elevated liver enzymes;no tx was given;pt reported that has hep C;
pain; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2, for COVID-19 immunisation.The following information was reported: PAIN (non-serious), outcome "unknown", described as "pain". Therapeutic measures were taken as a result of pain.  Additional information: Question: Call transferred from agent (name). The caller refused to provide demographic information. The caller stated she has been taking Tylenol for pain. She is has been taking 800mg of Motrin for that pain and she has not taken it because when she got the second Pfizer shot the nurse told her not to take any of anti-inflammatory medication. She asked if she can take it now. After providing verbal response, the caller still wanted to know if I could tell her if she could take the medication. - unable to offer warm transfer because the caller disconnected the call# e-transmitting AE details (unable to get additional details about the AE because the caller disconnected)  No follow-up attempts are possible, information about lot/batch number cannot be obtained.
RAISED RED LUMP GOLF BALL SIZE TENDER  MOM STATED EXTRA FUSSY SINCE THE VACCINE
Fever blisters; This case was reported by a consumer via interactive digital media and described the occurrence of fever blister in a patient who received Herpes zoster (Shingrix) for prophylaxis.   In February 2022, the patient received the 2nd dose of Shingrix. On an unknown date, less than a week after receiving Shingrix, the patient experienced fever blister. On an unknown date, the outcome of the fever blister was not recovered/not resolved.   It was unknown if the reporter considered the fever blister to be related to Shingrix.  Additional details were reported as follows:  The case was self-reported by the patient. The age at vaccination was not reported. The patient received 2nd Shingrix shot a week ago from reporting date.  The patient now had two fever blisters. The patient asked was that a common occurrence or just coincidence. Follow up would not be possible as contact details were not provided.
She got her vaccine, she did OK initially but slowly that day she began to feel sore at her injection site.  That evening is when she felt more pain at the injection site, then slowly traveled through her whole arm.  The next she had much more significant pain, lack of ROM, and just real tender the whole arm.  She did not notice any redness, the arm felt swollen, but when she looked in the mirror it was not significant swollen, but just has that sensation.  The pain has been the primary thing of the entire arm.  She can open and close her hand, but today was more limited and the inability to do lateral raise, bicep curls and to move in her normal way.  She was not given any medication, she does take OTC Aleve that she took and the medicine she takes for her chronic pain she has been using.  She declined taking Tylenol.  She has not been seen by the doctor.
pt recv vax NOV96 & exp a facial eruption;the eruption was dx as herpes simples 1;pt states that cont to exp monthly eruptions & that during times of the eruptions, pt is unable to work or have contact w/children;
fluid under the armpit: a lump. also headach, shakes, nausea and vomitting
About 45 minutes after the injection there was a swelling of the back of my tongue and throat.  It was difficult to swallow, but not difficult to breathe.  I took 25 mg of Benadryl and 4 hours later took 50 mg of Benadryl.  The swelling did not diminish, but did not get worse.  When I woke up the next morning, everything was back to normal.
This spontaneous report was received from a registered nurse concerning a patient of unknown age. The patient's pertinent medical history or concurrent conditions were not provided. Information regarding concomitant therapy was not reported. On 06-JUL-2017, the patient was vaccinated with an expired dose of M-M-R II, batch/lot# reported as: 024266, expiration date: 01-JUL-2017(dose number, anatomical location and frequency were not) for prophylaxis.
Swelling of eyes and lips and hives   Started around 10 PM and got progressively worse over night.  Went to medical facility in AM and was given  Decadron injection and scrip for steroid pac
Pt admitted for COVID pna, altered mental status and requiring o2. pt tx w/ dexamethasone and remdesivir
Pt feeling very nauseous, throwing up, pain in his tummy. very uncomfortable, dry heaving, could not sleep. for 10 hours now
pt recv vax &  23MAR96 exp chest congestion,low grade temp-not taken @ that time;t102.4 R,stuffy nose;25MAR96 breathing rapid,t99,APAP cont,good appetite,talked w/MD;26MAR96 irritable,t101,resp labored,periods of apnea
Severe pain in shoulder given 8-9-10 pain into joint. Swelling but no erythema. Had to put arm in a sling.
Mid upper abd pain since September 2012 (intermittent). Box 9: Possible gallbladder removal.
Pt was given the covid Vaccine and no visible reaction during there 15 min . staff vaccinated the patient after they realize the vaccine was passed it use date.
I have fatigue, cough, sore throat, headache, shortness of breath, and body aches. My cough has progressed a lot. I have not tested positive for COVID-19. I was prescribed doxycycline, TESSALON PRO, and ROBITUSSIN with codeine. I feel a little better today than I have been, but I still feel bad and have a bad cough.
BODY ACHES; UNWELL; FEVER; SEVERE HEADACHE; This spontaneous report received from a patient via a company representative. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient had no known drug allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch: unknown) dose was not reported, administered on 01-APR-2021 15:00 for prophylactic vaccination. The batch number was not reported and has been requested.   No concomitant medications were reported. On 01-APR-2021, the patient experienced severe headache. Laboratory data included: Body temperature (NR: not provided) 102 F. On 01-APR-2021, the patient experienced fever. On 01-APR-2021 21:00, the patient experienced body aches. On 01-APR-2021 21:00, the patient experienced unwell. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches, unwell, fever, and severe headache on 03-APR-2021. This report was non-serious.
A spontaneous, non-serious report of pregnancy was received from a registered nurse concerning a 29-year-old female patient. On 15-Sep-2009, the patient received FLUMIST. On 08-Oct-2009, the patient notified the nurse that she was pregnant. There as no adverse event experienced to date. Treatment and reporter/causality assessments are not applicable. The reporter was asked to inform when the pregnancy has ended and also to inform if the patient experiences any adverse events during the pregnancy.